title: CMV reactivation in nonmyeloablative HSCT.
authors.forename: C
authors.initials: C
authors.lastname: Graber
authors.forename: K N
authors.initials: KN
authors.lastname: de Almeider
authors.forename: R
authors.initials: R
authors.lastname: Childs
authors.forename: A J
authors.initials: AJ
authors.lastname: Barrett
authors.forename: V J
authors.initials: VJ
authors.lastname: Gill
authors.forename: J E
authors.initials: JE
authors.lastname: Bennett
mesh_terms: D016022:Case-Control Studies; D003587:Cytomegalovirus / Q000254:growth & development*; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008212:Lymphocyte Depletion; D019653:Myeloablative Agonists / Q000627:therapeutic use; D012189:Retrospective Studies; D013601:T-Lymphocytes; D014775:Virus Activation
chemical_list: D019653:Myeloablative Agonists